KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to $86.6 million.

  • Sarepta Therapeutics' Change in Acquisitions & Divestments fell 7094.04% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 2582.21%. This contributed to the annual value of $2.0 billion for FY2024, which is 715.18% up from last year.
  • As of Q3 2025, Sarepta Therapeutics' Change in Acquisitions & Divestments stood at $86.6 million, which was down 7094.04% from $68.6 million recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Change in Acquisitions & Divestments registered a high of $965.1 million during Q4 2024, and its lowest value of $30.0 million during Q3 2021.
  • Over the past 5 years, Sarepta Therapeutics' median Change in Acquisitions & Divestments value was $297.8 million (recorded in 2024), while the average stood at $320.9 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 123190.33% in 2022, then crashed by 9146.77% in 2025.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Change in Acquisitions & Divestments stood at $30.0 million in 2021, then soared by 1388.34% to $446.5 million in 2022, then grew by 18.3% to $528.2 million in 2023, then soared by 82.71% to $965.1 million in 2024, then tumbled by 91.03% to $86.6 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $86.6 million for Q3 2025, versus $68.6 million for Q2 2025 and $40.8 million for Q1 2025.